GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
305

[Meta] proposal — a flair for incretin posts

Paper Long Haul ×3

proposal — a flair for incretin posts. This affects how posts get sorted and removed, so it belongs in the open.

Started reading limitations sections first. It has changed how much weight I give to almost everything posted here.

The half-life explanation was the thing that made weekly dosing intuitive for me rather than arbitrary.

Tried to build a mental model from mechanism alone and produced a confident prediction that the trial data flatly contradicted.

That is everything I have. The rest is opinion and I have tried to keep it out.

487 up / 182 down73% upvoted7 commentsid x3h9aw11 Dec 2025

7 comments

5 in this archive, depth 3

best — the order this archive was captured in

u/vikram_mbeki26 points·7 months ago

The incretin effect is the observation that oral glucose provokes a larger insulin response than intravenous glucose at matched glycaemia, and the difference is mediated by gut hormones. That is the foundation the whole class sits on.

replysharereportpermalink
u/kavya_kravchenko-13 points·7 months ago

Is that from a human study or a preclinical model?

replysharereportpermalink
u/saskia_lokken1 point·7 months ago

Went looking for human data on a mechanism everybody here asserts. Found preclinical work and one small study. That was clarifying.

replysharereportpermalink
u/laila_almeida1 point·7 months ago

Push back: a receptor being expressed in a tissue does not tell you the agonist reaches it at therapeutic exposure.

replysharereportpermalink
u/rafael_ostergaard10 points·7 months ago·edited

Tolerance to the gastric effect develops with continued exposure while the appetite effect largely persists. That single fact explains most of the "it settles but it still works" pattern the side-effect board reports.

replysharereportpermalink
About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.